Form D · Other Health Care
Soovu Labs, Inc.
Seattle, WA · CIK 0001732662
Offering snapshot reported Dec 16, 2021 · SEC filing
- Reported sold
- $250K Offering amount: $2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 1, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 16, 2021 | Initial | $250,000 | No comparison | 2 | SEC filing |
| Feb 17, 2021 | Initial | $500,000 | No comparison | 2 | SEC filing |
| Jan 31, 2020 | Initial | $800,000 | No comparison | 1 | SEC filing |
| May 15, 2019 | Initial | $1,650,000 | No comparison | 7 | SEC filing |
| Jul 19, 2018 | Initial | $3,175,000 | No comparison | 7 | SEC filing |
| Feb 26, 2018 | Initial | $150,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-425429
Source: Form D, filed Dec 16, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Chabal | Director |
| Ronald Chwang | Director |
| Peter Dunbar | Director, Executive |
| Michaela Griggs | Director |
| Harold Kawaguchi | Executive |
| Allan Stephan | Director, Executive |
| Ed Yang | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2439 8th Avenue North
Seattle, WA, 98109
Seattle, WA, 98109